Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
The COVID Cold Chain: How a Vaccine Will Get to You

The COVID Cold Chain: How a Vaccine Will Get to You

Scientific American, November 19, 2020

Two drug companies have now reported highly successful results from phase III trials of COVID-19 vaccines. On November 18 Pfizer and partner BioNTech said their vaccine was 95 percent effective at preventing the disease, based on full trial results. Two days earlier Moderna reported its vaccine was 94.5 percent effective, based on interim data.

U.S.A. is Number One as COVID-19 Deaths Pass Quarter Million

U.S.A. is Number One as COVID-19 Deaths Pass Quarter Million

People's World, November 18, 2020

It’s probably not exactly what President Donald Trump meant when he borrowed the historic jingoistic slogan “America First” for his administration, but since early in the global COVID-19 pandemic, the U.S. has consistently held the Number One spot in coronavirus cases and deaths. It took less than two months for these numbers to grow from 200,000 to a mind-boggling 250,000 now.

Why Trump's Operation Warp Speed is Credited With Helping Face for COVID-19 Vaccine

Why Trump's Operation Warp Speed is Credited With Helping Face for COVID-19 Vaccine

CBC, November 19, 2020

Operation Warp Speed, a Trump administration initiative to manufacture COVID-19 vaccines as fast as possible, should be lauded as a successful endeavour in what has otherwise been a poor effort to deal with the coronavirus, experts say. "No doubt, Operation Warp Speed is a huge success," said Tinglong Dai, associate professor of Operations Management and Business Analytics at Johns Hopkins University Carey Business School in Baltimore.

Vaccine Poses Immense, Unprecedented Distribution Challenges

Vaccine Poses Immense, Unprecedented Distribution Challenges

Manufacturing Net, November 19, 2020

Reports of spiking COVID-19 cases and related fatalities have been met with recent news of extremely promising vaccines developed by Pfizer and Moderna. With the two offerings promising 90 and 95 percent effectiveness against the virus, respectively, attention now turns to mass production and, more importantly, mass distribution. According to Anna Nagurney, Ph.D., Director of the Virtual Center for Supernetworks and professor at the Department of Operations and Information Management at the University of Massachusetts, distribution is where the biggest challenges lie.

COVID-19 Vaccine Distribution, Shipping Present Challenges

COVID-19 Vaccine Distribution, Shipping Present Challenges

NBC DFW, November 18, 2020

With COVID-19 cases rising across the country, the need for a safe and reliable vaccine is increasing. Both Pfizer and Moderna have announced vaccine trials with more than 90% effectiveness. Creating vaccines and getting federal approval are only the first hurdles which are followed by finding ways to transport the highly-perishable vaccines to millions of Americans.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

AI’s energy impact is still small—but how we handle it is huge

AI’s energy impact is still small—but how we handle it is huge

DJNews, May 21, 2025

With seemingly no limit to the demand for artificial intelligence, everyone in the energy, AI, and climate fields is justifiably worried. Will there be enough clean electricity to power AI and enough water to cool the data centers that support this technology? These are important questions with serious implications for communities, the economy, and the environment. 

Healthcare

Want to reduce the cost of healthcare? Start with our billing practices.

Want to reduce the cost of healthcare? Start with our billing practices.

The Hill, March 11, 2025

Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive. 

Supply Chain

US-China 90-day tariff deal brightens trade and economic outlook

US-China 90-day tariff deal brightens trade and economic outlook

Fast Markets, May 13, 2025

The recent US-China agreement to temporarily reduce tariffs is a major step for global trade, with tariffs on US goods entering China dropping from 125% to 10% and on Chinese goods entering the US decreasing from 145% to 30% starting May 14. While this has boosted markets and created optimism, key industries like autos and steel remain affected, leaving businesses waiting for clearer long-term trade policies.

Items to Stock Up on Before Trump's Tariffs Take Effect

Items to Stock Up on Before Trump's Tariffs Take Effect

Newsweek, May 8, 2025

With sweeping new tariffs on Chinese-made products set to take effect this summer, Americans are being urged to prepare for price hikes on everyday goods. President Donald Trump's reinstated trade policies are expected to affect a wide swath of consumer imports, including electronics, furniture, appliances, and baby gear. Retail experts are advising shoppers to act before the tariffs hit and prices rise.

Climate